2026 Volume 51 Issue 11 Pages 621-630
Electrophilic compounds can activate the Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, which protects cells against ferroptosis, while simultaneously inhibiting selenium metabolism and glutathione peroxidase 4 (GPx4) expression, potentially promoting ferroptosis. However, how these opposing activities affect ferroptosis susceptibility remains unclear. In this study, we investigated the effects of the monocarbonyl curcumin derivative GO-Y015, a potent Nrf2 activator, on ferroptosis in HT-1080 cells. GO-Y015 activated Nrf2 and induced heme oxygenase-1 more strongly than curcumin and provided greater protection against ferroptosis induced by erastin or RSL3. Inhibition of Nrf2 activity by ML385 abolished the protective effect of GO-Y015, supporting a substantial contribution of Nrf2 activation to its anti-ferroptotic activity. In contrast, GO-Y015 inhibited selenium-dependent induction of GPx4, consistent with our previous findings that GO-Y015 inhibits selenium metabolism. Selenite suppressed ferroptosis concomitantly with GPx4 induction; however, its protective effect was not additive with that of GO-Y015, despite the opposing effects of the two compounds on GPx4 expression. These findings indicate that GO-Y015 can provide substantial protection against ferroptosis through Nrf2-dependent cytoprotective responses despite impaired selenium-dependent GPx4 induction under the present experimental conditions. Our findings suggest that Nrf2 activation can contribute to cellular protection against ferroptosis even when selenium metabolism is impaired.